Insider Transactions by Yea Christopher

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherCHIEF DEVELOPMENT OFFICERFeb 20, 2024Sale$14.1112,053170,12472,895Feb 21, 2024, 09:48 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherCHIEF DEVELOPMENT OFFICERFeb 14, 2024Sale$15.0139,886598,66166,160Feb 16, 2024, 04:18 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerNov 20, 2023Sale$8.237,11358,53546,046Nov 21, 2023, 04:32 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerAug 18, 2023Sale$10.737,14276,62441,662Aug 21, 2023, 08:06 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerMay 18, 2023Sale$10.142,60426,41637,310May 19, 2023, 09:20 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerFeb 17, 2023Sale$7.662,72720,88935,709Feb 23, 2023, 05:42 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerNov 18, 2022Sale$5.441,1396,19634,232Nov 21, 2022, 04:21 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerAug 17, 2022Sale$14.961,14517,13033,597Aug 19, 2022, 05:16 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerNov 01, 2021Sale$18.075,00090,32832,969Nov 03, 2021, 04:56 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerAug 02, 2021Sale$20.525,000102,57837,969Aug 04, 2021, 07:55 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerFeb 23, 2021Sale$33.5915,000503,87762,169Feb 25, 2021, 08:25 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 29, 2020Sale$17.485,00087,39462,969Nov 02, 2020, 08:01 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 20, 2020Sale$17.497,942138,88676,315Oct 22, 2020, 05:36 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 21, 2020Sale$18.256,044110,28270,513Oct 22, 2020, 05:36 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerOct 16, 2020Sale$17.0091415,53981,955Oct 20, 2020, 02:14 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerFeb 05, 2020Sale$17.101001,71082,869Feb 07, 2020, 05:18 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerDec 20, 2019Option Exercise$8.515,29245,03785,615Dec 26, 2019, 05:32 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerDec 12, 2019Sale$8.503983,38483,168Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerDec 13, 2019Option Exercise$8.523,00025,57484,469Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerDec 16, 2019Option Exercise$8.536,02051,33185,979Dec 16, 2019, 07:34 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerJul 22, 2019Sale$9.1714,710134,96190,324Jul 24, 2019, 05:53 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerApr 22, 2019Sale$13.0214,710191,56190,324Apr 23, 2019, 05:33 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerJan 25, 2019Option Exercise$8.5310,90693,03988,422Jan 29, 2019, 06:53 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerJan 22, 2019Option Exercise$8.502,60422,14584,271Jan 24, 2019, 07:48 PM
KALVKalVista Pharmaceuticals, Inc.Yea ChristopherChief Development OfficerJan 23, 2019Option Exercise$8.511,20010,20883,569Jan 24, 2019, 07:48 PM